Press Releases – Page 2

Jeanne Hecht Joins Pro-ficiency Board of Directors

June 23, 2022/315 Comments/in News, Press Releases/by Collin Brooks

Durham, North Carolina, June 23rd, 2022 – Pro-ficiency completes its strategic board expansion initiative with the appointment of Jeanne Hecht to the organization’s Board of Directors.

“Considering Jeanne’s reputation as a visionary in clinical trials, her appointment is an incredible win for Pro-ficiency,” said Pro-ficiency President and Founder, Dave Hadden. “Her impact on both small and large organizations is profound. Having her guidance is going to be integral to ensuring that we’re continuing to innovate, meet emerging and existing challenges in the profession, and that we’re setting new standards for how companies make study-related decisions”.

“I have a passion for helping companies with high-impact solutions realize their potential and Pro-ficiency provides a unique opportunity to revolutionize how companies are using human performance to take proactive action in their studies,” said Hecht. “The opportunities are endless so I’m excited to provide any guidance I can to ensure strategic, effective growth so more organizations can evolve how they think about learning within their organizations”.

Jeanne Hecht currently serves as CEO of JTH Consulting, LLC and serves as Non-Executive Director on life science and healthcare IT Boards of Directors. Her leadership in clinical trials spans over 25 years from CEO of Ora, COO of Median Technologies and senior roles at IQVIA, VP of Marketing and Sales for Decision Biomarkers, Inc. and Regulatory Affairs Officer for the UNC Oncology Protocol Office.

Hecht’s expertise in adult learning runs deep as she currently serves as Advisory Board Member for the University of North Carolina Chapel Hill Kenan-Flagler’s Business School Center for the Business of Health. She is also a founder member of the Wake Forest University’s master’s in clinical research program and remains an active industry advisor to the school.

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Robin Newman Joins Pro-ficiency Board of Directors

June 9, 2022/252 Comments/in News, Press Releases/by Collin Brooks

Durham, North Carolina, June 9th, 2022 – Pro-ficiency continues to expand its thought leadership representation on their Board of Directors with the addition of Robin Newman, RN, MSN, EdD, CPNP.

“We hit the jackpot when Robin agreed to join our Board. The breadth of her leadership across the clinical trials landscape is astounding, but her doctorate in organizational learning and development means she really understands what we do, how it’s done, and how it impacts clinical trials” said Pro-ficiency President and Founder, Dave Hadden. “Her insights on how to apply our approach for medical devices is going to be a game changer for us too.”

“When you look at the root cause of many of the pervasive issues facing clinical trials, they stem from human understanding” said Dr. Newman. “I’ve been in leadership in clinical trials for decades and Pro-ficiency’s approach is one of the few solutions I’ve seen that I truly believe can move that needle in a meaningful direction, for sponsors, for sites and for patients. Joining the Board of Directors was an easy decision”.

For more than 25 years, Dr. Newman has dedicated her career to building better futures for patients through developing healthcare solutions in the medical device and biopharmaceutical industries. As a leader in business and philanthropy, Dr. Newman has her research roots firmly planted in the healthcare industry, beginning as a Clinical Research Coordinator and Pediatric Nurse Practitioner to her current role as Global VP for Clinical Affairs at Beckman Coulter Diagnostics and Life Sciences.

She holds both Bachelor and Master degrees in Nursing from the University of Texas at Austin and Arlington, where she was honored as a Distinguished Alumni, and a doctorate in Human & Organizational Learning and Development from The George Washington University.

Prior to joining Beckman Coulter, Dr. Newman served as the WW VP for Clinical Affairs and WW Vice President, Clinical, Preclinical and Medical Strategic R&D at Johnson & Johnson, the Director of the Office of Compliance at the Center for Devices and Radiological Health, US Food & Drug Administration, VP Quality, Regulatory, and Clinical Affairs at Siemens Healthcare Diagnostics, and Founder and CSO of MedTrials, a clinical research and regulatory consulting firm headquartered in Dallas, Texas. Dr. Newman has also served as member and Chair of the Board of Trustees for the Association of Clinical Research Professionals.

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Dr. Jeffrey Kasher Joins Pro-ficiency Board of Directors

June 2, 2022/266 Comments/in News, Press Releases/by Collin Brooks

Durham, North Carolina, June 2nd, 2022 – Pro-ficiency, a pioneer in the field of simulation-based training in clinical trials, has opened up a select number of seats on the Company’s Board of Directors. Dr. Jeffrey Kasher, a renowned visionary in clinical trials with over 28 years of experience at organizations like Eli Lilly, is the first to join as the newest Director.

Dr. Kasher is known to be a driving force behind innovation in clinical trials. From being an early and consistent advocate of the importance of patient engagement while President of Patients Can’t Wait to serving on the board of – and advisor to – some of the most impactful organizations in clinical research, Kasher is a visionary leader and a change agent.

“Jeff is the King of clinical trial innovation, so saying we are thrilled that he has joined our Board is an understatement. We believe that Pro-ficiency can have one of the most profound impacts on clinical trials by turning decisions into data. With Jeff’s insights and advice, we can finally change what this industry has come to accept from their training,” said Pro-ficiency President and Founder, Dave Hadden. “Jeff only dedicates his time to efforts that move the needle and the fact that he has chosen to hop on this rocket ship of ours speaks volumes.”

“At first, the concept of simulation-based training in clinical trials was interesting, but once I fully understood the power of the solution to de-risk studies, I knew I wanted on board,” said Dr. Kasher. “It is both a unique approach to a ubiquitous element of study start-up but an elegantly simple one as well. It’s rare that I see a solution that solves problems without adding layers of complexity for sites.”

Currently, Jeff serves as the President of Patients Can’t Wait, and is an Advisory Board member for Be the Partner, BlueCloud, and Wake Forest masters in clinical research management program. He advises several multinational Pharmaceutical companies and CROs, and emerging technology companies, and serves on the Board of Catalyst Clinical Research. He has been named one of the CenterWatch “20 Innovators Changing the Face of the Clinical Trials Industry.”

Jeff received a B.S. in Chemistry from Franklin & Marshall College, a Ph.D. in Pharmacology from the State University of New York, and a Post-Doctoral fellowship in Physiology at Yale University School of Medicine.

About Pro-ficiency

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at proficiency3.wpengine.com.

Contact:

Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420

Pro-ficiency Selected as Participant in DPharm Idol Disrupt

October 7, 2021/in News, Press Releases/by Collin Brooks

Pro-ficiency was selected as a participant in the DPharm Idol Disrupt program, hosted at the Disruptive Innovations conference September 28-29, 2021.

RALEIGH N.C. – FOR IMMEDIATE RELEASE: [September 30, 2021]

Idol Disrupt, now in its 11th year, aims at featuring companies with a disruptive technology or service that would be a changing force for clinical trials. This year, six companies were charged with producing a five-minute recorded presentation, followed by quick-fire questions from a panel of judges to showcase their innovation. Pro-ficiency highlighted the power and impact of their simulation platform during their session.

Pro-ficiency’s mission to eliminate protocol deviations, one study at a time, through the use of their proprietary simulation-based training methodology targets the single greatest FDA inspection finding year over year – non-adherence to the protocol. Simulation achieves this by allowing study sites to practice critical elements of the protocol in a consequence-free environment, improving understanding and retention of the key protocol content. The resulting behavior-based performance analytics help sponsors and CROs proactively address sites, individuals, or even protocol elements that have the highest risk potential.

“With such an innovative group of finalists, we were honored just to be selected to participate in Idol Disrupt,” said David Hadden, President and Co-Founder of Pro-ficiency. “We have the capability to tangibly help the industry by looking at training differently, and Idol Disrupt is the ideal platform to help companies better understand that we’re not just another twist on traditional training.”

About Pro-ficiency:

Pro-ficiency is a leading provider of tech-enabled training and compliance solutions for clinical trials. The company provides a comprehensive suite of services, including a turn-key offering of customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. For more information, please visit www.proficiency3.wpengine.com.

For further information about Pro-ficiency, schedule a demo: http://proficiency1.wpenginepowered.com/contact-us/

New Standard in GCP Training Announced by ACRP

March 8, 2021/in Press Releases/by Collin Brooks

FOR IMMEDIATE RELEASE: [March 8, 2021]

CONTACT:
Jeremy Glunt
+ 1.703.258.3506
media@acrpnet.org

New Standard in GCP Training Announced by ACRP

Immediately Available Free of Charge to ACRP Members

Washington, DC – The Association of Clinical Research Professionals (ACRP) just launched a new Good Clinical Practice (GCP) Simulation training program that sets a new standard for GCP training compliance and competency development.

Developed in partnership with Pro-ficiency, a leading provider of tech-enabled training and compliance solutions for clinical trial investigators and site staff,

this interactive simulation-based program develops real-world GCP competency while making the learning experience more effective, less time consuming, and more enjoyable.

“As the cornerstone of clinical research, quality GCP training is of paramount importance; yet until today, clinical research professionals have been forced to rely on antiquated training programs that fail to engage learners or develop competency,” says ACRP Executive Director Jim Kremidas. “Starting now, professionals and organizations alike have immediate access to a modern training program that engages learners and develops real-world competency.”

What makes ACRP’s GCP Simulation unique is its sharp focus on the application of GCP principles rather than the acquisition of knowledge. By immersing learners in a cutting-edge adaptive learning environment, this program builds strength in the critical thinking and decision making needed to apply GCPs in the real world.

“For years we have seen the positive impact adaptive, simulation-based training has on performance and we are thrilled to partner with ACRP to bring this approach to such a critical and ubiquitous component of clinical research training,” says David D. Hadden, Co-Founder and Chief Game Changer, Pro-ficiency. “Further, ACRP’s bold move to make the program available to all ACRP members, combined with Pro-ficiency’s inclusion of the program with all protocol simulation programs, will both increase site staff performance and reduce bothersome training redundancies for study teams.”

Playing the roles of study coordinator, investigator, sub-investigator, research nurse, and study monitor/CRA in a variety of simulated scenarios, course participants develop a 360-degree understanding of GCP principles while practicing the application of associated competencies in a safe environment – before mistakes are made in real studies.

For experienced professionals, this program is an ideal solution for GCP training compliance. With a solid foundation in GCP knowledge and application, experienced professionals should be able to progress through scenarios quickly and efficiently – and get back to work.

For those new to the field, ACRP’s GCP Simulation offers a fun and engaging way to develop GCP competencies by practicing in a risk-free environment. When course correction is required, coaching is immediately provided – including reference to applicable GCP guidelines and contextualization of associated principles.

For organizations, performance metrics help managers target development needs for their team members and the standard 2-year renewal cycle automates the renewal cycle and ensures teams stay compliant with study requirements.

For more information, including organizational licensing options, please visit acrpnet.org/gcpsim.

***

About ACRP

In clinical research, people are everything. ACRP raises clinical research standards and accelerates careers. Better people. Better results. www.acrpnet.org

About Pro-ficiency

Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at proficiency3.wpengine.com.

Seasoned Healthcare Executive Michael Raymer joins Pro-ficiency as CEO

March 2, 2021/in Press Releases/by Collin Brooks

FOR IMMEDIATE RELEASE: [March 2, 2021]

Seasoned Healthcare Executive Michael Raymer joins Pro-ficiency as CEO

RALEIGH N.C. & DURHAM, N.C. Release Date: [March 2, 2021]- Pro-ficiency, the
leading provider of simulation-enabled, experiential training for clinical research, is
excited to announce the appointment of Michael Raymer to the position of Chief
Executive Officer.

Raymer joins Pro-ficiency with over 25 years of executive experience in the
development of healthcare enterprise software, medical devices, diagnostics, and
consumer health products including leadership positions at Perspective Diagnostics,
M*Modal, Microsoft, GE Healthcare and Nellcor Puritan Bennett.

“Michael is exactly who we need for this next phase of growth at Pro-ficiency” says
JoAnne Schaberick, Co-Founder and Chief Awesomeness Officer. “He has the vision,
strategic leadership, and experience to continue building Pro-ficiency as the premier
provider in clinical research training and compliance.”

“Pro-ficiency is in a truly unique position to meet an urgent market need, and to do so in
a way that improves clinical trial conduct long term. Simulation-based training has been
the standard in so many mission-critical professions for years. The pandemic has been
the tipping-point for clinical trials to adopt new training approaches that will likely remain
the standard in the future,” said Raymer. “I am excited to join the Pro-ficiency team as
we drive this important change for how study training is conducted and managed, now
and for years to come.”

“When we started Pro-ficiency in 2013, it was with a vision of transforming the way our
industry thinks about human performance management. Michael shares this vision,”
says Co-Founder and Chief Game Changer Dave Hadden. “The world needs engaged
and informed investigators more than ever and I couldn’t be more excited to have
Michael helping us lead this charge.”

Raymer’s appointment follows the recent announcement of a strategic growth equity
investment by NovaQuest Private Equity. In its six years since inception, Pro-ficiency
has experienced rapid growth in sponsor and CRO appointments on complex Phase 3
global studies, with recent expansion into the Phase 2 study arena and the company’s
selection as the exclusive eLearning provider for the Association of Clinical Research
Professionals (ACRP). As CEO, Raymer is positioned to expedite Pro-ficiency’s growth
trajectory and position the organization as a leader in the study start-up and clinical
trials training space.

Dave Hadden and JoAnne Schaberick will continue in their roles as Chief Game
Changer and Chief Awesomeness Officer, leading continued innovation, growth and
exceptional client relations at Pro-ficiency.

About Pro-ficiency:
Pro-ficiency is a leading provider of tech-enabled training and compliance solutions for
clinical trials. The Company provides a comprehensive suite of services, including a
turn-key offering of customized, virtual training simulations, training and compliance
monitoring tools, and real-time data &; predictive analytics. For more information, please
visit www.proficiency3.wpengine.com.

About NovaQuest Private Equity:
NovaQuest Private Equity is a leading investor in technology and services companies in
the life sciences and healthcare sectors. NovaQuest was formed in 2000 with the vision
of building an investment platform to provide strategic capital and operational leverage
in partnership with strong management teams. The investment team consists of highly
seasoned operational and investment professionals with significant investment
experience and deep life science and healthcare expertise. Furthermore, NovaQuest
benefits from an extensive network of industry experts and relationships that assist in
identifying, analyzing, and growing NovaQuest portfolio companies and investments.
For more information, please visit www.novaquest.com.

Pro-ficiency to Accelerate Growth with Major Investment from NovaQuest Private Equity

February 23, 2021/in Press Releases/by Collin Brooks

Pro-ficiency to Accelerate Growth with Major Investment from NovaQuest Private Equity
NovaQuest acquires majority interest in leading, simulation-based clinical trial training innovator
For immediate release: 23 February 2021

RALEIGH; DURHAM, NC –(BUSINESS WIRE)– February 23, 2021 — NovaQuest Private Equity (“NovaQuest”) today announced its strategic growth equity investment in Pro-ficiency, LLC (“Pro-ficiency”), a leading provider of tech-enabled training and compliance solutions for clinical trial investigators and site staff.

Based in Durham, NC, Pro-ficiency provides innovative, virtual simulation training and HR compliance solutions for clinical trials, supported by original content creation and analytics services. Leading pharmaceutical companies engage Pro-ficiency to deploy customized, study-specific training solutions that improve learning retention and strengthen compliance among investigators and site staff. The company’s platform also provides sponsors and CROs with real-time analytics that help to predict and avoid study errors and protocol violations, ultimately reducing the time, cost, and failure points of clinical trials. This integrated suite of services provides a compelling value proposition to its pharmaceutical customers.

“Pro-ficiency is excited to partner with NovaQuest, a firm with unparalleled global pharma and life sciences relationships and a proven track record of successfully supporting market-leading businesses in their next phase of growth,” said David Hadden, Co-Founder of Pro-ficiency. “With NovaQuest’s growth equity investment, Pro-ficiency is well-funded to continue changing the paradigm of clinical trial training.”

“Our customers are developing innovative products that require rigorous compliance across increasingly complex and global trials,” said JoAnne Schaberick, Co-Founder of Pro-ficiency. “NovaQuest’s expertise in life sciences and clinical trials will be invaluable as we continue to expand our team and offering to consistently surpass expectations and meet the needs of our valued customers.” “Dave and JoAnne are pioneers in the use of simulation-based training to improve healthcare. They have done an outstanding job developing a platform that addresses a critical, unmet need for better clinical trial training solutions,” said Michael Sorensen, Partner at NovaQuest. “We look forward to supporting the Pro-ficiency team as it meets unprecedented demand for its mission-critical clinical trial training solutions.”

Wyrick Robbins served as legal advisor to Pro-ficiency, and Smith Anderson served as legal advisor to NovaQuest. Deal terms were not announced.

About Pro-ficiency:
Pro-ficiency is a leading provider of tech-enabled training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including a turn-key offering of customized, virtual training simulations, training and compliance monitoring tools, and real-time data; predictive analytics.
For more information, please visit www.proficiency3.wpengine.com.

About NovaQuest Private Equity:
NovaQuest Private Equity is a leading investor in technology and services companies in the life sciences and healthcare sectors. NovaQuest was formed in 2000 with the vision of building an investment platform to provide strategic capital and operational leverage in partnership with strong management teams. The investment team consists of highly seasoned operational and investment professionals with significant investment experience and deep life science and healthcare expertise. Furthermore, NovaQuest benefits from an extensive network of industry experts and relationships that assist in identifying, analyzing, and growing NovaQuest portfolio companies and investments. For more information, please visit www.novaquest.com.

For further information about Pro-ficiency, please contact:

David Hadden, Co-Founder
(919) 904-0035, dave@pro-ficiency.com

JoAnne Schaberick, Co-Founder
(619) 840-0875, joanne@pro-ficiency.com

For media inquiries, please contact:
Jeremy Milner, BackBay Communications
(401) 862-9422, jeremy.milner@backbaycommunications.com

TissueTech Announces Engagement of Pro-ficiency Virtual Study Trainer™ for Clinical Trials

December 21, 2020/in Press Releases/by Collin Brooks

FOR IMMEDIATE RELEASE

For More Information, Contact:

Barbara Getz

305-370-5708

bgetz@tissuetechinc.com

TissueTech Announces Engagement of Pro-ficiency Virtual Study Trainer™ for Clinical Trials

Miami, FL – November 19, 2020 – TissueTech, Inc., an emerging biotechnology company and pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today the engagement of Pro-ficiency Virtual Study Trainer™ to facilitate remote study protocol training for TissueTech’s clinical trial investigators and their clinical research teams.

TissueTech has been quick to integrate proven technologies to meet the rapidly changing clinical trial industry landscape during the pandemic and maintain compliance with FDA guidance. Even in the best of times, effectual training on complicated protocols is a challenge. Ensuring investigator compliance with regulatory guidelines is paramount to building a foundation for any successful trial. Recognizing the costs and risks associated with face-to-face training and needing a proven solution, TissueTech selected Pro-ficiency to ensure success in their late-breaking Diabetic Foot Ulcer study in this new operating environment.

“As we were evaluating ways to leverage innovative technologies to solve some of the challenges faced with launching late-breaking trials amidst the onset of the pandemic, investigator training was a specific area of focus and concern,” said Tommy Lee, Vice President of Clinical Operations at Tissue Tech. “Pro-ficiency uniquely stood out from the available options providing critical measures of protocol understanding through simulation training. This method was very attractive as it optimized the investigator’s ability to learn through immersive and engaging real-world scenarios designed to test their understanding of the trial’s protocol.”

Pro-ficiency’s Virtual Study Trainer ™ uses the most advanced Remote Site Performance Management technology in the industry. Offering both Virtual IM™ and Virtual SIV™, Pro-ficiency aids in avoiding the cost and complexity of travel and scheduling and training every investigator and site staff to the highest performance standards possible. Remote learning at Pro-ficiency utilizes simulation-training and remote site performance management, ensuring virtual training is just as effective as the face-to-face alternative.

Pro-ficiency CEO David Hadden says: “We are proud to be working alongside TissueTech on a meaningful, innovative project targeting an unmet medical need in diabetic patients living with complex diabetic foot ulcers and in need of advanced wound management.”

About TissueTech, Inc.

TissueTech, Inc., the parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., is a scientific and market leader in the field of regenerative medicine. TissueTech manufactures a broad range of ocular, surgical, wound care, and soft tissue products that are marketed under these subsidiaries. Since the company’s inception, clinicians have performed more than 500,000 human implants of the company’s products and published more than 360 peer-reviewed studies supporting its platform technology. TissueTech is committed to an unwavering culture of integrity that places our patients’ safety and clinical outcomes above all else. Learn more at https://tissuetech.com/.

Pro-ficiency Appoints Jenna Rouse As VP of Client Success

December 17, 2020/in Press Releases/by Collin Brooks

PRO-FICIENCY APPOINTS JENNA ROUSE AS VP OF CLIENT SUCCESS

This year’s most exciting news! Jenna Rouse has joined the team at Pro-ficiency as the VP of Client Success.

Durham, NC — December 1, 2020

Jenna Rouse has been turning heads and lighting up minds in the training industry since she joined the Association for Clinical Research Professionals (ACRP) 16 years ago. Her expertise in building partnerships and new business opportunities for ACRP quickly led to her development of a strong understanding of the training gaps and needs among CROs, Sponsors and sites within the clinical research enterprise. Her move to Pro-ficiency is a testament to the growth and exciting future of our organization.

“Our company has grown to where it became clear we needed to expand our team to ensure continued outstanding customer support and innovative solutions. I have known Jenna professionally for several years, and when the opportunity arose to bring her onto the Pro-ficiency team, we knew it was a win for the organization, and for our valued clients” –JoAnne Schaberick, Co-CEO at Pro-ficiency.

“I loved working with Pro-ficiency as their client” says Rouse. “The Pro-ficiency platform and simulation programs are truly ground-breaking in the clinical research space and I knew I needed to be a part of a company with that kind of vision”.

Jenna will work with the Executive Sales Team to manage mature, existing and new business accounts, and generate additional business opportunities within that client base. Her attention to high standards and superior client relationships is sure to add to our continual success.

About Pro-ficiency

Pro-ficiency utilizes simulation-training, eMentoring, and analytics to train researchers to the highest performance standards possible. Leading the virtual revolution in remote site support, we provide remote site training, compliance and communication tools to 60,000+ clinical researchers globally. Our virtual toolkit helps study teams meet the challenge of training and communicating with sites.

Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at proficiency3.wpengine.com.

Source: Pro-ficiency LLC

Pro-ficiency and Scarritt Group Join Forces to Create Comprehensive Solutions for Virtual Investigator Meetings and Site Initiation Visits

August 21, 2020/in Press Releases/by Collin Brooks

DURHAM, N.C., August 18, 2020 (Newswire.com) – Pro-ficiency and Scarritt Group Inc. are pleased to announce that they have entered into a global strategic partnership, combining Pro-ficiency’s unique simulation-based trial training technology with Scarritt Group’s Virtual Conference Center to offer a comprehensive solution for Virtual Investigator Meetings and Site Initiation Visits.

“Since the pandemic, pharmaceutical sponsors have been struggling to replace traditional face-to-face investigator meetings with a virtual solution. To do this effectively, you need to carefully consider all the objectives of an IM and what blend of technology does the best job with each of those objectives,” said Pro-ficiency co-CEO Dave Hadden. “There are three main objectives of an IM: train your investigators, meet them to develop a solid working relationship with them, and build interest and excitement about your study. Virtual-IM™ provides a best-in-class offer that satisfies those three objectives.”

After the training and investigator meeting is conducted, Scarritt and Pro-ficiency offer Virtual-SIV™ which manages all site onboarding activities such as staff training and site inspection.

The combined Scarritt and Pro-ficiency solution offers the best-in-class approach for each of these objectives. Pro-ficiency’s Virtual Study Trainer uses advanced simulation training technology to assess and train investigators to the maximum performance levels possible, and all online and asynchronously. “When the investigator comes to Scarritt’s Virtual Conference Center for the live component of the meeting, we already know their strengths and knowledge gaps so the study teams can focus the meeting agenda on the areas with the highest risk,” commented Adrienne Williams, Scarritt CEO. “Engaging investigators online is hard when you lose the face-to-face component. Our VCC facilitates face-to-face interactions between investigators and study team members to develop those connections. We also use proprietary AI-avatars and live conference facilitators to keep the investigators interested and engaged in the meeting.”

Scarritt and Pro-ficiency have been utilizing these virtual products for over five years. This is not new to them and they have had time to perfect the approach. Together, the companies have conducted over 2,000 virtual investigator meetings and provided virtual study training to over 120,000 investigators.

About Scarritt Group

Scarritt Group is an international meeting planning and logistics company that focuses on providing clinical meetings. Scarritt Group was founded in 1999 and has substantial knowledge in meeting planning for many different industries. Learn more at scarrittgroup.com.

About Pro-ficiency

Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at proficiency3.wpengine.com.

Source: Pro-ficiency LLC